CODEXIS INC. - COMMON STOCK

Codexis to Participate in Jefferies Global Healthcare Conference

22 May 2024 16:25:41 By Nasdaq GlobeNewswire

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

20 May 2024 16:05:14 By Nasdaq GlobeNewswire

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

14 May 2024 06:00:00 By Nasdaq GlobeNewswire

Codexis Reports First Quarter 2024 Financial Results

02 May 2024 16:05:00 By Nasdaq GlobeNewswire

Codexis to Report First Quarter 2024 Financial Results on May 2

18 Apr 2024 16:05:10 By Nasdaq GlobeNewswire

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

11 Apr 2024 07:05:13 By Nasdaq GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

28 Feb 2024 16:05:01 By Nasdaq GlobeNewswire

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

26 Feb 2024 16:05:42 By Nasdaq GlobeNewswire

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

26 Feb 2024 08:05:47 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

20 Feb 2024 08:05:01 By Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

14 Feb 2024 16:05:29 By Nasdaq GlobeNewswire

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

13 Feb 2024 16:05:59 By Nasdaq GlobeNewswire

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

01 Feb 2024 16:05:07 By Nasdaq GlobeNewswire

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

27 Dec 2023 08:30:58 By Nasdaq GlobeNewswire

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

13 Dec 2023 16:06:00 By Nasdaq GlobeNewswire

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

13 Dec 2023 16:05:38 By Nasdaq GlobeNewswire

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

11 Dec 2023 07:05:49 By Nasdaq GlobeNewswire

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

28 Nov 2023 16:05:24 By Nasdaq GlobeNewswire

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

14 Nov 2023 16:05:36 By Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2023 Financial Results

02 Nov 2023 16:05:01 By Nasdaq GlobeNewswire